Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Management of cancer Stories

2014-01-27 08:27:54

Trial to evaluate ID-G100 in patients with Merkel cell carcinoma SEATTLE and SOUTH SAN FRANCISCO, Calif., Jan. 27, 2014 /PRNewswire/ -- Immune Design, a clinical-stage biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced treatment of the first patient in a Phase 1 clinical trial of ID-G100 in patients with Merkel cell carcinoma (MCC). (Logo: http://photos.prnewswire.com/prnh/20130926/SF87058LOGO)...

2014-01-24 13:27:45

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective. Reporting in the journal Cell Reports, researchers combined several types of data from pre- and post-treatment biopsies of breast tumors to obtain a molecular picture of how the cancer evolved as a result of chemotherapy. "Better understanding of tumor evolution is key to improving the...

2014-01-20 23:03:53

GIA announces the release of a trend report on Cancer Stem Cells. Market for Cancer Stem Cells is projected to witness strong growth led by high prevalence of cancer worldwide, unmet medical needs in cancer treatment and diagnosis, strong investments in R&D, and supportive regulatory and reimbursement policies. San Jose, California (PRWEB) January 20, 2014 Follow us on LinkedIn – Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal,...

2014-01-16 04:20:52

New collaboration aims to push cancer diagnostics to the next level SINGAPORE, Jan. 16, 2014 /PRNewswire/ -- A collaboration between National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) has resulted in the establishment of the region's first Circulating Tumour Cell Centre of Research Excellence (CTC CoRE). This new Centre facilitates the use of circulating tumour cells (CTCs)[1] in...

2014-01-14 11:05:11

Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division and prevented growth of advanced cancer cells. In a study described in the January 13 issue of Cancer-Cell, Marikki Laiho, M.D., Ph.D., and her colleagues say their work focused on the ability of a chemical dubbed BMH-21 to sabotage the transcription pathway RNA...

2014-01-13 23:25:01

The IDSA and its best skateboarders are set to partake in history, as they try to seek new world records for men and women in distance skated during a 24-hour time period. The Homestead Miami Speedway will host history on January 20-21, 2014. Miami, FL (PRWEB) January 13, 2014 The 24 Hour Ultraskate will be returning to Homestead-Miami Speedway in 2014. On January 20, 2014, both Andy Andras and Colleen Pelech will defend their 2013 UltraSkate titles and records against some of the...

2014-01-09 11:35:24

Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it's possible a simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue. This appears possible following the discovery that tiny particles the size of viruses called 'exosomes,' which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer...

2014-01-08 16:26:14

FDA Study Aimed at Harnessing Immune System to Fight Tumors Now Available at All Five Hospital Sites CHICAGO, Jan. 8, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA), a leading provider of innovative cancer care for patients living with complex and advanced-stage disease, is now enrolling patients in an ovarian cancer vaccine clinical trial at all five of its hospital sites. CTCA Western Regional Medical Center (WRMC) in suburban Phoenix, Arizona and...

2014-01-07 08:31:48

LOS ANGELES, Jan. 7, 2014 /PRNewswire/ -- Interim results from a clinical trial of Prostate Health Cocktail (PHC®) show promise that OncoNatural's over-the-counter dietary supplement may soon become a widely recognized adjunct treatment for prostate disease. Prostate specific antigen, or PSA, was effectively stabilized in more than 83% of study participants. Equally important, PHC demonstrated far less impact on quality of life and physical wellbeing metrics when compared with traditional...

2014-01-04 23:02:32

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that discusses a new brain cancer treatment that will specifically target glioblastomas. New York, NY (PRWEB) January 04, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by MySunCoast.com that takes a deeper look into a new brain cancer treatment that will...